Lorence H. Kim, Chief Financial Officer at Moderna, Inc. (MRNA), sold 241,000 shares at $58.30 ($14.1M) on 2020-06-02, disclosed to the SEC on 2020-06-04.
Open-market sale of $14.1M MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RVMD | BUY | 2022-07-25 | $1.0M | — | Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $166K | — | Filing → |